Status:
COMPLETED
Engagement 2.0 Forms of Consent for Data (re-)Use
Lead Sponsor:
Universitair Ziekenhuis Brussel
Conditions:
Alzheimer Disease, Early Onset
Mild Cognitive Impairment
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this qualitative study is to create a better understanding of patients' mental model of health data engagement interfaces and tools (such as Dynamic Consent). The researchers will foc...
Detailed Description
While unprecedented amounts of multimodal health data become increasingly available and their secondary use in clinical and (bio)medical research holds great promise, people's agency over this data is...
Eligibility Criteria
Inclusion
- no diagnosed cognitive impairment but first-degree relative with AD
- mild cognitive impairment due to AD (diagnosed according to the NIA/AA diagnostic criteria)
- mild dementia due to AD (diagnosed according to the NIA/AA diagnostic criteria)
Exclusion
- Patients with moderate to severe dementia due to AD, defined as MMSE total score 20/30 or lower
Key Trial Info
Start Date :
August 17 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2023
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT05229978
Start Date
August 17 2022
End Date
February 1 2023
Last Update
February 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitair Ziekenhuis Brussel (UZB)
Jette, Brussels Capital, Belgium, 1090